Pattern of hMLH1, hMSH2 and hMSH6 expression and clinical characteristics in a sample of Malaysian colorectal carcinoma cases

Malaysian Journal of Pathology

Volumn 35, Issue 1, 2013, Pages 45-57

  Khoo, Joon Joon ^a,b,c   Gunn, Andrew ^c   Peh, Suat Cheng ^b  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c HOSPITAL SULTANAH AMINAH   (Malaysia)

Author keywords

Colorectal carcinoma; Immunohistochemical stain; Mismatch repair defect

Indexed keywords

DNA; MISMATCH REPAIR PROTEIN; MUCIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; ARTICLE; CANCER INCIDENCE; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA RECOMBINATION; DNA REPLICATION; FEMALE; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MISMATCH REPAIR; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALAYSIA; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879590993     PISSN: 01268635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. National Cancer Registry. Malaysian Cancer Statistics-Data and Figure Peninsular Malaysia. [World Wide Web:]: Ministry of Health Malaysia; 2006; 1-136. Available from: www. makna.org.my/ PDF/MalaysiaCancerStatitics.pdf.
2. Modrich P, Lahue R. Mismatch repair in replication fi delity, genetic recombination, and cancer biology. Annu Rev Biochem. 1996; 65: 101-33.
3. Harfe BD, Jinks-Robertson S. DNA mismatch repair and genetci instability. Annu Rev Genet. 2000; 34: 359-99.
4. Li GM. The role of mismatch repair in DNA damage-induced apoptosis. Oncol Res. 1999; 11(9): 393-400.
5. Stojic L, Brun R, Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst). 2004; 3(8-9): 1091-101.
6. Tiraby JG, Fox MS. Marker discrimination in transformation and mutation of pneumococcus. Proc Natl Acad Sci U S A. 1973; 70(12): 3541-5.
7. Cunningham JM, Kim CY, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet. 2001; 69(4): 780-90.
8. Wright CL, Stewart ID. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Am J Surg Pathol. 2003; 27(11): 1393-406.
9. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993; 363(6429): 558-61.
10. Chapusot C, Martin L, Mungra N, et al. Sporadic colorectal cancers with defective mismatch repair display a number of specifi c morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas. Histopathology. 2003; 43(1): 40-7.
11. Millar AL, Pal T, Madlensky L, et al. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet. 1999; 8(5): 823-9.
12. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999; 81(2): 214-8.
13. Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology. 2000; 119(4): 921-8.
14. Lim SB, Jeong SY, Lee MR, et al. Prognostic signifi cance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis. 2004; 19(6): 533-7.
15. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. In: Kleihues P, Sobin LH, editors. World Health Organization classifi cation of tumours. Lyon: IARC Press; 2000.
16. Department of Statistics Malaysia. Population Distribution and Basic Demographic Characteristics. Department of Statistics Malaysia; 2007.
17. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002; 20(4): 1043-8.
18. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: defi nition and correlation with mismatch repair protein expression. Cancer Res. 1997; 57(21): 4749-56.
19. Dieumegard B, Grandjouan S, Sabourin JC, et al. Extensive molecular screening for hereditary nonpolyposis colorectal cancer. Br J Cancer. 2000; 82(4): 871-80.
20. Cawkwell L, Gray S, Murgatroyd H, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut. 1999; 45(3): 409-15.
21. Stone JG, Robertson D, Houlston RS. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair defi cient colorectal cancer. J Clin Pathol. 2001; 54(6): 484-7.
22. Valentini AM, Armentano R, Pirrelli M, Gentile M, Caruso ML. Immunohistochemical mismatch repair proteins expression in colorectal cancer. Appl Immunohistochem Mol Morphol. 2006; 14(1): 42-5.
23. Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer. 2000; 36(1): 49-54.
24. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000; 342(2): 69-77.
25. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003; 349(3): 247-57.
26. Bertagnolli MM, Niedzwiecki D, Compton CC, et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fl uorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol. 2009; 27(11): 1814-21.
27. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fl uorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004; 126(2): 394-401.
28. Jover R, Zapater P, Castells A, et al. The effi cacy of adjuvant chemotherapy with 5-fl uorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer. 2009; 45(3): 365-73.
29. Jover R, Payá A, Alenda C, et al. Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis. Am J Clin Pathol. 2004; 122(3): 389-94.
30. Percesepe A, Borghi F, Menigatti M, et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol. 2001; 19(19): 3944-50.
31. Ward R, Meagher A, Tomlinson I, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001; 48(6): 821-9.
32. Mangold E, Pagenstecher C, Friedl W, et al. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol. 2005; 207(4): 385-95.
33. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998; 58(8): 1713-8.
34. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998; 58(15): 3455-60.
35. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998; 95(12): 6870-5.
36. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996; 2(2): 169-74.
37. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997; 113(4): 1146-58.
38. Potocnik U, Glavac D, Golouh R, Ravnik-Glavac M. Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening. Cancer Genet Cytogenet. 2001; 126(2): 85-96.
39. Wheeler JM, Loukola A, Aaltonen LA, Mortensen NJ, Bodmer WF. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet. 2000; 37(8): 588-92.
40. Yamamoto H, Min Y, Itoh F, et al. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosomes Cancer. 2002; 33(3): 322-5.
41. Wu Y, Berends MJ, Mensink RG, et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet. 1999; 65(5): 1291-8.
42. Chai SM, Zeps N, Shearwood AM, et al. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients. Clin Gastroenterol Hepatol. 2004; 2(11): 1017-25.
43. Kakar S, Burgart LJ, Thibodeau SN, et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer. 2003; 97(6): 1421-7.
44. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev. 1999; 9(1): 89-96.
45. Young J, Simms LA, Biden KG, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001; 159(6): 2107-16.
46. Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining. Arch Pathol Lab Med. 2003; 127(6): 694-700.
47. Ma AH, Xia L, Littman SJ, et al. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability. Oncogene. 2000; 19(18): 2249-56.
48. Leung WK, Kim JJ, Wu L, Sepulveda JL, Sepulveda AR. Identifi cation of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J Biol Chem. 2000; 275(21): 15728-32.
49. Messerini L, Vitelli F, De Vitis LR, et al. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinicopathological variables. J Pathol. 1997; 182(4): 380-4.
50. Molaei M, Mansoori BK, Ghiasi S, Khatami F, Attarian H, Zali M. Colorectal cancer in Iran: immunohistochemical profi les of four mismatch repair proteins. Int J Colorectal Dis. 2010; 25(1):63-9.
51. Hatch SB, Lightfoot HM, Jr., Garwacki CP, et al. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-defi cient tumors. Clin Cancer Res. 2005; 11(6): 2180-7.
52. Ashktorab H, Smoot DT, Carethers JM, et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003; 9(3):1112-7.
53. Wu AH, Shibata D, Yu MC, Lai MY, Ross RK. Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. Carcinogenesis. 2001; 22(10): 1681-4.
54. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D, Samowitz W. Dietary intake and microsatellite instability in colon tumors. Int J Cancer. 2001; 93(4): 601-7.
55. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001; 61(1): 126-30.
56. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control. 1997; 8(2): 146-58.
57. Gaglia P, Atkin WS, Whitelaw S, et al. Variables associated with the risk of colorectal adenomas in asymtomatic patients with a family history of colorectal cancer. Gut. 1995; 36(3): 385-90.
58. Breivik J, Lothe RA, Meling GI, Rognum TO, Børresen-Dale AL, Gaudernack G. Different genetic pathways to proximal and distal colorectal cancer infl uenced by sex-related factors. Int J Cancer. 1997; 74(6): 664-9.
59. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994; 7(4): 536-40.
60. Hameed F, Goldberg PA, Hall P, Algar U, van Wijk R, Ramesar R. Immunohistochemistry detects mismatch repair gene defects in colorectal cancer. Colorectal Dis. 2006; 8(5): 411-7.
61. Feeley KM, Fullard JF, Heneghan MA, et al. Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis. J Pathol. 1999; 188(1): 14-7.
62. Gafà R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer. 2000; 89(10): 2025-37.
63. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994; 145(1): 148-56.
64. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998; 42(5): 673-9.
65. Risio M, Reato G, di Celle PF, Fizzotti M, Rossini FP, Foà R. Microsatellte instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res. 1996; 56(23): 5470-4.
66. Lothe RA, Peltomäki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993; 53(24): 5849-52.
67. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993; 260(5109): 816-9.
68. Rosty C, Chazal M, Etienne MC, et al. Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metstases from patients with colorectal cancer: relationship with response to 5-fl uorouracil and survival. Int J Cancer. 2001; 95(3): 162-7.
69. Liang JT, Huang KC, Lai HS, et al. Highfrequency microsatellite instability predicts better chemosensitivity to high-dose 5-fl uorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection. Int J Cancer. 2002; 101(6): 519-25.
70. Ruschoff J, Wallinger S, Dietmaier W, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci U S A. 1998; 95(19): 11301-6.
71. Yamamoto H, Itoh F, Fukushima H, Hinoda Y, Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer. 1999; 84(4): 400-3.
72. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000; 342(26): 1946-52.